Report Precision Cancer Medicine

About Precision Cancer Medicine

“Precision cancer medicine,” in which treatment is tailored to each individual according to cancer characteristics such as genetic mutations, is expected to play an important role in the future.

However, “Precision cancer medicine” is currently limited in the number of medical indications, (a) the number of medical indications for its use is still quite limited; (b) it involves the use of genetic information; and (c) the costs of testing and treatment are often expensive. Due to these characteristics, various issues have arisen in developing personalized cancer care throughout Japan without bias.

HGPI launched the “Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society” in the summer of 2021, and generates policy advocacy for future cancer control.

[Event Report] The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)
2024-04-19

[Event Report] The Project for Considering the Future of Precision Medicine with Industr ...>>

[Announcement] HGPI Endorsed “Joint Statement on the Implementation of Comprehensive Genomic Profiling test” (December 15, 2023)
2023-12-21

[Announcement] HGPI Endorsed “Joint Statement on the Implementation of Comprehensive Gen ...>>

[Event Report] Diet Member study session: “Challenges and Prospects for Improving Patient Access to Genomic Cancer Medicine” (December 12, 2023)
2023-12-18

[Event Report] Diet Member study session: “Challenges and Prospects for Improving Patien ...>>

[Event Report] The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Policy Dialogue Event “Challenges and Prospects for the Improving Patient Access to Genomic Cancer Medicine” (October 11, 2023)
2023-11-06

[Event Report] The Project for Considering the Future of Precision Medicine with Industr ...>>

[Event Report] HGPI and the Japan Pharmaceutical Manufacturers Association’s Aging Group Joint Symposium “Health Challenges that Accompany Population Aging – Dementia and Cancer.” (September 8, 2023)
2023-10-31

[Event Report] HGPI and the Japan Pharmaceutical Manufacturers Association’s Aging Group ...>>

[Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, 2023)
2023-08-10

[Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, ...>>

[Research Report] Results of Internet Survey on Genomic Cancer Medicine (Summary)(May 11, 2023)
2023-06-12

[Research Report] Results of Internet Survey on Genomic Cancer Medicine (Summary)(May 11 ...>>

[Event Report] The 113th HGPI Seminar – Current Circumstances and Issues in Precision (Genomic) Cancer Medicine (March 2, 2023)
2023-04-12

[Event Report] The 113th HGPI Seminar – Current Circumstances and Issues in Precision (G ...>>

[Public Comment Submission] “Basic Plan for the Promotion of Cancer Control (Draft)” (February 18, 2023)
2023-02-27

[Public Comment Submission] “Basic Plan for the Promotion of Cancer Control (Draft ...>>

[HGPI Policy Column] No. 33 – From the NCDs (Precision Cancer Medicine) Team, What is precision cancer medicine?
2023-02-02

[HGPI Policy Column] No. 33 – From the NCDs (Precision Cancer Medicine) Team, What is pr ...>>

[Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
2022-11-02

[Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Propo ...>>

[Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
2022-03-09

[Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (M ...>>

PageTop